Suicidality in patients with premenstrual dysphoric disorder–A systematic review and meta-analysis

Haohao Yan,Yudan Ding,Wenbin Guo
DOI: https://doi.org/10.1016/j.jad.2021.08.082
IF: 6.533
2021-12-01
Journal of Affective Disorders
Abstract:BackgroundWhether premenstrual dysphoric disorder (PMDD) is correlated with the risk of suicidality and the extent of its effect on suicidality are unclear. The present study was conducted to elucidate the association between PMDD and suicidality from relevant studies.MethodsFour electronic databases, namely, Scopus, Embase, PubMed, and Web of Science, were searched from inception to November 15, 2020. Quality assessment, data synthesis, and sensitivity analysis were performed on the included studies.ResultsSix studies with 8 532 participants were included in this meta-analysis. PMDD was associated with an increased risk of suicidal ideation (odds ratio [OR]=2.34, 95% confidence interval [CI]=1.50–3.18, I2=0.0%, p=0.99, k=4). Patients with PMDD had a greater risk of experiencing suicide attempt (OR=2.13, 95% CI=1.05–3.21, I2=0.0%, p=0.81, k=5). PMDD was associated with an increased risk of suicidal plan (OR=2.24, 95% CI=1.03–3.45, I2=0.0%, p=0.96, k=2).LimitationsThe diagnosis of PMDD should be considered "provisional" in all the included studies.ConclusionsAmong PMDD sufferers there would be a group of particularly suicidal women. Clinicians who treat patients with PMDD should be vigilant for signs of suicidal ideation and behavior to implement better treatment and preventive measures.
psychiatry,clinical neurology
What problem does this paper attempt to address?